September 16, 2024 3:28 PM

Govt approves revolutionary six-month treatment for drug-resistant TB

The Union Ministry of Health & Family Welfare has approved the introduction of a novel treatment regimen for multidrug-resistant tuberculosis (MDR-TB) under its National TB Elimination Program (NTEP). The new BPaLM regimen, a four-drug combination of Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin, promises to revolutionize MDR-TB treatment in India. This shorter, six-month treatment option is set to replace the traditional 20-month procedure, offering higher success rates with fewer s...